摘要
目的 :检测结直肠癌患者血清p5 3抗体 (p5 3Ab)的敏感性和特异性 ,并了解其与肿瘤组织p5 3的相关性和临床意义。方法 :检测 2 0 0 2年 7月至 2 0 0 3年 12月的结直肠癌病例 178例。对照组为 4 0例正常健康志愿者。血清p5 3Ab检验采用酶联免疫法 :肿瘤组织p5 3蛋白表达测定应用免疫组化SP染色法。结果 :178例结直肠癌中33例血清p5 3Ab阳性 ,阳性率 18.5 4 % ;4 0例对照组检测阴性 ,特异性 10 0 %。血清p5 3Ab与患者的年龄、性别和肿瘤发生的部位无关 (P >0 .0 5 ) ;血清p5 3Ab阳性为Dukes’分期B期 (16 / 71,2 2 .5 4 % )、C期 (12 / 5 5 ,2 1.82 % )和D期(5 / 30 ,16 .6 2 % )。 10 3例肿瘤组织p5 3蛋白阳性 (5 7.87% ) ,75例阴性 (4 2 .13% ) ;血清p5 3Ab阳性者 6 9.7%组织表达阳性 ,30 .3%组织表达阴性 (P <0 .0 5 )。随访 6～ 2 4个月 ,肿瘤复发率在血清p5 3Ab阳性和阴性患者间无显著性差异 ;平均存活时间亦无统计学意义。结论 :研究表明血清p5 3Ab的产生伴有肿瘤组织p5 3蛋白的积聚 ;因为抗体检测的低敏感性 ,血清p5 3Ab不能作为术前的肿瘤指标 ;但由于它的高特异性 。
Purpose:We evaluated the sensitivity and specificity of p53 antibodies (p53-Ab) as a preoperative tumor marker and as a prognosis marker in colorectal cancer patients and we also investigated whether p53-Ab production is dependent on p53 protein overexpression in tumor tissue.Methods:Serum samples from 178 colorectal cancer patients and 40 healthy controls were tested for the presence of p53-Ab by using an ELISA kit. Expression of p53 protein in tumors was determined using mouse anti-human p53-Ab.Results:Serum p53-Ab was detected in 18.54% of patients while all controls were negative. A strong correlation between p53-Ab production and p53 protein expression was observed: 69.7%of p53-Ab positive cases had tumors positive for p53 vs 30.3%of p53-Ab negative cases. There was also a significant predominance of p53-Ab positive cases in Dukes ’ stages B (16/71,22.54%), C (12/55,21.82%)and D(5/30,16.67%)over stage A. No difference in patients’ age, sex and localization was found between the p53-Ab positive and negative groups. Recurrence of cancer did not differ between p53-Ab positive and negative patients after a median follow-up of 13.5 months and also median survival time did not vary significantly.Conclusions:There was a significant correlation between p53-Ab production in serum and p53 protein expression in tumor tissue. Because of their low sensitivity (18.54%) p53-Ab are not suitable as a preoperative tumor marker. However, their high specificity (100%) and their potential for early diagnosis of a tumor relapse makes them valuable for postoperative monitoring during follow-up in p53- Ab positive patients.[
出处
《中国癌症杂志》
CAS
CSCD
2004年第5期429-431,共3页
China Oncology
